China Medicine Stock Analysis

China Pink Sheet Analysis Notes

The company has price-to-book (P/B) ratio of 0.07. Some equities with similar Price to Book (P/B) outperform the market in the long run. China Medicine recorded a loss per share of 0.01. The entity had not issued any dividends in recent years. China Medicine Corporation produces and distributes prescription and over the counter drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. China Medicine Corporation was founded in 2005 and is based in Guangzhou, China. CHINA MEDICINE operates under Medical Distribution classification in the United States and is traded on OTC Exchange. It employs 281 people.The quote for China Medicine is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on China Medicine please contact Senshan Yang at 86 20 8739 1718 or go to https://www.cmc621.com/cmc/index.php.

China Medicine Investment Alerts

China Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 284.54 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate China Medicine's market, we take the total number of its shares issued and multiply it by China Medicine's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

China Profitablity

The company has Profit Margin (PM) of 0.09 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.18 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.18.

Technical Drivers

As of the 2nd of December, China Medicine shows the Risk Adjusted Performance of 0.1035, mean deviation of 2.98, and Standard Deviation of 12.31. China Medicine technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm China Medicine coefficient of variation, total risk alpha, as well as the relationship between the Total Risk Alpha and skewness to decide if China Medicine is priced correctly, providing market reflects its regular price of 2.0E-4 per share. As China Medicine appears to be a penny stock we also recommend to validate its information ratio numbers.

China Medicine Price Movement Analysis

China Medicine Predictive Daily Indicators

China Medicine Forecast Models

China Medicine's time-series forecasting models are one of many China Medicine's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary China Medicine's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how China Medicine prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling China shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as China Medicine. By using and applying China Pink Sheet analysis, traders can create a robust methodology for identifying China entry and exit points for their positions.

When running China Medicine's price analysis, check to measure China Medicine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy China Medicine is operating at the current time. Most of China Medicine's value examination focuses on studying past and present price action to predict the probability of China Medicine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move China Medicine's price. Additionally, you may evaluate how the addition of China Medicine to your portfolios can decrease your overall portfolio volatility.